The ZERO Prostate Cancer's appeal for CDC funding
By Howard Wolinsky
Sorry to bother you again.
There was a glitch in the links I sent on the ZERO Prostate Cancer campaign to try to save funding for prostate cancer at the Centers for Disease Control and Prevention.
To let your Congressional delegation know where you stand, click here: https://zerocancer.quorum.us/campaign/dcpc/
Ali Manson, government relations & advocacy for ZERO Prostate Cancer, noted:
On May 2nd, the White House released its draft budget proposal for Fiscal Year 2026 that includes devastating cuts to public health. Most alarming is the complete elimination of the CDC's Division of Cancer Prevention and Control.
This elimination would wipe out cancer registries that track cancer cases nationwide, end critical funding for state health departments' cancer prevention efforts, terminate prostate cancer awareness and education programs, and dismantle ALL cancer prevention activities at the CDC.
These programs save lives through early detection, education, and prevention. Without them, millions of Americans will lose access to vital cancer screening and prevention resources that could mean the difference between early detection and late-stage diagnosis.
Thankfully, these cuts are not set in stone. Congress can prevent them. Can you take just a minute or two to tell your legislators that these cuts are unacceptable to our community?
If you would like to learn more about these potential cuts, I invite you to read our latest Prostate Pulse entry.
UMiami’s Dr. Sanoj Punnen to Cover ‘The Great Biopsy Debate’ at ASPI Webinar May 24
The debate over transperineal vs. transrectal biopsies continues, a critical topic in prostate cancer diagnosis. There have been four randomized trials in the past year alone with somewhat contradictory results, impacting prostate cancer management.
Active Surveillance Patients International (ASPI)’s monthly webinar will focus on these issues in a program entitled, “The Biopsy Debate: Where Do We Stand on Transperineal vs. Transrectal?”
Researcher Sanoj Punnen, MD, professor of urologic oncology at the University of Miami, will be the featured speaker.
(Dr. Sanoj Punnen, University of Miami)
The program will be on Saturday, May 24 from noon to 1:30 pm Eastern. Please register here.
Dr. Punnen is Vice Chair of Research, Desai Sethi Urology Institute, and Co-Chair of Genitourinary Site Disease Group, Sylvester Comprehensive Cancer Center, University of Miami Leonard M. Miller School of Medicine. His research interests include prostate cancer biomarkers, imaging, and genomic markers for prostate cancer risk and monitoring.
He is the lead investigator on two prospective clinical trials validating the 4KScore test, a novel blood-based biomarker for predicting the risk of clinically significant prostate cancer and the need for biopsy. He is also the Principal Investigator on an ongoing NCI-funded clinical trial examining the impact of prostate MRI and tissue-based genomic prognostic signatures in men undergoing Active Surveillance for prostate cancer.
Please send questions in advance to: contactus@aspatients.org.
The Active Surveillor Features Uropathologist Dr. Jonathan Epstein in May 17 webinar
The Active Surveillor is hosting a webinar entitled, “What You Need to Know About Your Prostate Biopsy—The New News,” featuring renowned uropathologist Dr. Jonathan Epstein.
Saturday, May 17 at Noon - 1:30 pm Eastern.
Register here
Hosted by The Active Surveillor with ASPI and AnCan Foundation
Join Dr. Jonathan Epstein (Ep-Stine) and Howard Wolinsky on Saturday May, 17. The program will focus on men on early Active Surveillance but also consider those contemplating or doing radiation therapy and surgery.
Hosted by The Active Surveillor with ASPI and AnCan Foundation, the program will focus on men on early Active Surveillance but also consider those contemplating or undergoing radiation therapy or surgery.
Dr. Epstein recently launched Advanced Uropathology of New York after nearly 40 years on the faculty at Johns Hopkins University School of Medicine. His expertise in uropathology makes this a must-attend event for prostate cancer patients.
If you have questions for Dr. Epstein, please send them to howard.wolinsky@gmail.com.
Additional Prostate Cancer Insights
This month in my other blog, Prostate Cores: “Kidney stones/gallstones linked with prostate cancer?” Explore research connecting these conditions to prostate cancer risk.
I want someone who thinks it's a good idea to eliminate cancer prevention funding to explain to me why. It's hard for me to accept that Republican & Christans honestly believe that only "the libs" get cancer, or that they don't know anyone personally who has been hit by it.
That leaves two choices that I can think of. One, they think they can pray away the cancer, or two, increasing the death rate gets them closer to the rapture.